Cargando…
Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality?
Evidence for increased risk of cardiovascular morbidity and mortality in chronic inflammatory rheumatic diseases has accumulated during the last years. Traditional cardiovascular risk factors contribute in part to the excess of cardiovascular risk in these patients and several mechanisms, including...
Autores principales: | Bartoloni, Elena, Alunno, Alessia, Valentini, Valentina, Luccioli, Filippo, Valentini, Eleonora, La Paglia, Giuliana Maria Concetta, Leone, Maria Comasia, Cafaro, Giacomo, Marcucci, Elisa, Gerli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297850/ https://www.ncbi.nlm.nih.gov/pubmed/30619884 http://dx.doi.org/10.3389/fcvm.2018.00177 |
Ejemplares similares
-
Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?
por: Bartoloni, Elena, et al.
Publicado: (2019) -
Insulin-Like Growth Factor Binding Protein 6 in Rheumatoid Arthritis: A Possible Novel Chemotactic Factor?
por: Alunno, Alessia, et al.
Publicado: (2017) -
Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome
por: Alunno, Alessia, et al.
Publicado: (2018) -
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020) -
Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New
por: Alunno, Alessia, et al.
Publicado: (2012)